Blueprint Medicines Corp (BPMC)
107.20
+0.20
(+0.19%)
USD |
NASDAQ |
May 03, 16:00
107.20
0.00 (0.00%)
After-Hours: 18:41
Blueprint Medicines Gross Profit (Quarterly): 71.70M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 71.70M |
September 30, 2023 | 53.78M |
June 30, 2023 | 55.25M |
March 31, 2023 | 60.11M |
December 31, 2022 | 33.93M |
September 30, 2022 | 62.98M |
June 30, 2022 | 31.66M |
March 31, 2022 | 57.65M |
December 31, 2021 | 99.47M |
September 30, 2021 | 20.40M |
Date | Value |
---|---|
June 30, 2021 | 20.80M |
March 31, 2021 | 21.47M |
December 31, 2020 | 33.98M |
September 30, 2020 | 744.97M |
June 30, 2020 | 8.216M |
March 31, 2020 | 6.143M |
December 31, 2019 | 51.53M |
September 30, 2019 | 9.139M |
June 30, 2019 | 5.11M |
March 31, 2019 | 0.73M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
5.11M
Minimum
Jun 2019
744.97M
Maximum
Sep 2020
76.23M
Average
33.98M
Median
Dec 2020
Gross Profit (Quarterly) Benchmarks
Alnylam Pharmaceuticals Inc | 353.86M |
Apellis Pharmaceuticals Inc | 126.46M |
Ionis Pharmaceuticals Inc | 321.44M |
Madrigal Pharmaceuticals Inc | -- |
Sarepta Therapeutics Inc | 362.90M |